← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2006First marketed drug
Jun 15, 2000First NDA
Jun 15, 2000Last known activity
Nov 30, 2025
Timeline
1970s
- Jan 1, 1979
Debiopharm— Founded
2000s
- Jun 15, 2000
triptorelin— NDA Organization
2010s
- Feb 1, 2014
Affinium Pharmaceuticals, Ltd— Acquired
Drugs by trial phase (46 distinct, 55 trials)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (17 own, 1 via acquisition)
Phase 1 (16 own, 0 via acquisition)
Indications
Approved for
Studied for
- Acute Lung Injury
- Adenocarcinoma
- Arthritis, Infectious
- Bacterial Infections
- Bone Diseases
- Bone Diseases, Infectious
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Chronic Pain
- Communicable Diseases
- Esophageal and Gastric Varices
- Fibrosis
- Heart Failure
- Hemorrhage
- Hepatic Insufficiency
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hypertension
- Hypertension, Portal
- Infections
- Inflammation
- Kidney Failure, Chronic
- Liver Diseases
- Liver Failure
- Lung Diseases
- Lung Neoplasms
- Lymphoma
- Neoplasms
- Prostatic Neoplasms
- Puberty, Precocious
- Pulmonary Fibrosis
- Renal Insufficiency
- Respiration Disorders
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Tract Diseases
- Squamous Cell Carcinoma of Head and Neck
- Syndrome
- Varicose Veins
Marketed drugs (1)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT06930625Lead sponsorPhase 3Nov 30, 2025
- NCT07035769Lead sponsorPhase 1Jun 18, 2025
- NCT06969430Lead sponsorPhase 1/Phase 2May 30, 2025
- NCT06612203CollaboratorPhase 1/Phase 2Jan 31, 2025
- NCT06395753Lead sponsorPhase 2May 23, 2024
- NCT06225284CollaboratorPhase 2Feb 15, 2024
- NCT06129539Study directorPhase 3Dec 31, 2023
- NCT06129539Lead sponsorPhase 3Dec 31, 2023
- NCT05815160Lead sponsorPhase 1May 2, 2023
- NCT05706129Lead sponsorPhase 1/Phase 2Mar 14, 2023
- NCT05765812Study directorPhase 1/Phase 2Mar 1, 2023
- NCT05765812Lead sponsorPhase 1/Phase 2Mar 1, 2023
- NCT05364944Lead sponsorPhase 1May 18, 2022
- NCT05109975Lead sponsorPhase 1Nov 30, 2021
- NCT04962724Lead sponsorPhase 1Aug 2, 2021
Details
- Founded
- Lausanne, CH Jan 1, 1979
- First NDA
- Jun 15, 2000
- Last known activity
- Nov 30, 2025